FDA
approval
· 2023-03-03
FDA Approved: TIAGABINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
Summary
FDA approved a supplemental application for tiagabine hydrochloride from Teva Pharmaceuticals USA, Inc., indicating a labeling-related regulatory action.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for TIAGABINE HYDROCHLORIDE (TIAGABINE HYDROCHLORIDE)